Type 1 Diabetes

Researchers Identify Endothelial Markers Correlated With Kidney Disfunction in T1D

November 25th 2021, 5:10pm


Results of a prospective study revealed several endothelial markers are associated with kidney dysfunction among children with type 1 diabetes.

Cynthia Rice on How Build Back Better Could Make Insulin Out-of-pocket Cost Consistent

November 23rd 2021, 4:00pm


Cynthia Rice, MPP, JDRF chief mission strategy officer, explains how Build Back Better would affect the cost of insulin.

100 Years After Insulin's Discovery, Disparities Persist

November 17th 2021, 5:15pm


Writing in The Lancet, researchers discuss disparities in type 1 diabetes care on the 100th anniversary of the discovery of insulin.

Sex Differences in Glycemic Measures Seen Following Exercise in T1D

November 15th 2021, 5:45pm


Findings of a small study conducted in Brazil indicate exercise prescribed to patients with type 1 diabetes (T1D) may need to be tailored based on sex.

Dr Robert Gabbay: Diabetes Clinical Trials Should Be More Inclusive

November 11th 2021, 5:15pm


Robert A. Gabbay, MD, PhD, chief scientific and medical officer at the American Diabetes Association, explains why clinical trials need to be inclusive and how the Health Equity Now initiative is working to recruit more diverse populations with diabetes.

Research Finds SGLT2 Inhibitors May Yield CV, Renal Benefits in Patients With T1D

November 8th 2021, 6:37pm


Research presented at Kidney Week 2021 suggests sodium-glucose co-transporter 2 inhibitors may show beneficial cardiovascular (CV) and kidney effects among patients with type 1 diabetes.

Investigators Devise EHR Workflow to Support T1D Glycemic Improvement

November 5th 2021, 8:45pm


In an effort to improve glycemic outcomes among patients with type 1 diabetes (T1D), researchers created an electronic health record (EHR) workflow to measure self-management habits.

Study Details Brain Matter Changes, Cortical Thinning Among Patients With T1D, Neuropathy

October 30th 2021, 4:30pm


Researchers found individuals with type 1 diabetes and neuropathy exhibit altered gray matter volume and cortical thickness compared with healthy controls.

Dr Robert Gabbay on New ADA and EASD Type 1 Diabetes Guidance

October 28th 2021, 9:02pm


Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA), discusses the most important takeaways from recent guidance on type 1 diabetes from the ADA and European Association for the Study of Diabetes (EASD).

Assessing the Relationship Between Vitamin D Deficiency, T1D, and Coronary Disease

October 27th 2021, 6:14pm


Researchers in Poland examined the impact of vitamin D deficiency on patients with type 1 diabetes undergoing pancreas transplants.